Treg/regulatory B-cell/TAM modulator (Jounce Therapeutics)

N/A

Report date: 2025/06/11 10:38:21
NME

Base Information

Drug NameTreg/regulatory B-cell/TAM modulator (Jounce Therapeutics)
Drug Alias NameN/A
ClassificationSmall molecules
Mechanisms of ActionB-lymphocyte inhibitorsRegulatory T-lymphocytes inhibitorsImmunostimulants +[4] 
TargetsUpdating
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesJounce Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesJounce Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A